Kent Armeson to Risk Factors
This is a "connection" page, showing publications Kent Armeson has written about Risk Factors.
Connection Strength
0.108
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
Score: 0.020
-
Swallowing Outcomes in Elderly Patients following Microvascular Reconstruction of the Head and Neck. Otolaryngol Head Neck Surg. 2018 08; 159(2):320-327.
Score: 0.019
-
Physical and emotional well-being and support in newly diagnosed head and neck cancer patient-caregiver dyads. J Psychosoc Oncol. 2017 Nov-Dec; 35(6):646-665.
Score: 0.018
-
Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Arch Dermatol Res. 2017 May; 309(4):243-251.
Score: 0.018
-
Family history of cutaneous and noncutaneous malignancies in relation to the risk of keratinocyte carcinoma coupled with another type of cancer: A case-control study. J Am Acad Dermatol. 2016 Nov; 75(5):1066-1068.e7.
Score: 0.018
-
Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors. Cancer. 2013 Sep 15; 119(18):3385-92.
Score: 0.014